The document discusses mathematical models for pandemics like COVID-19. It summarizes existing SIR, SEIR, and SAIR models and proposes a new model. For this new model, it finds that reported daily infections (NT), active infections (T), and cumulative removed cases (RT) for many locations over time follow a linear relationship of T = bNT + e/(P0)*(T + RT), suggesting this could be used to estimate the transmission rate parameter. Analysis of data from India, US and other locations at different phases supports this relationship.
1. The document discusses various epidemiological measurements including counts, rates, ratios, and proportions. It provides examples and formulas for calculating crude rates, adjusted rates, and specific rates.
2. Incidence is defined as the rate of new cases of a disease in a population over time. There are two approaches to measuring incidence - cumulative incidence rate and incidence density rate.
3. The document is a draft for a course on measurements and calculations in epidemiology, providing instruction on important concepts and formulas.
This document discusses various measurement tools used in epidemiology including rates, ratios, proportions, prevalence, and incidence. It provides examples of how to calculate crude rates, specific rates, ratios, and proportions. Prevalence refers to all existing cases at a point in time or over a period of time. Incidence refers only to new cases occurring over a time period. Relationships between incidence, prevalence, and duration of disease are also examined.
This document discusses various methods for measuring disease frequency and trends. It defines key epidemiological terms like prevalence, incidence, odds ratio, and relative risk. It explains how to calculate these measures and interpret them. For example, it shows how to calculate the odds ratio from a 2x2 table to measure the association between alcohol use and accidents. It also discusses factors that can indicate a causal relationship and gives examples of time series analysis of disease trends over time.
This document discusses different measures of morbidity including frequency, duration, and severity. Frequency is measured by incidence and prevalence. Incidence refers to new cases in a defined time period, while prevalence refers to all current cases. Duration is measured by disability rate and severity by case fatality rate. The document provides definitions and formulas for calculating incidence rate, point prevalence, and period prevalence. It also discusses factors that influence prevalence and the relationship between incidence and prevalence.
Crude Rate, Age Adjusted Rate, Age Specific Rates in CancerRamnath Takiar
This document provides an overview of basic statistical principles related to cancer registration. It defines key terms like cancer, cancer registration, crude rate, age-specific rate, and age-adjusted rate. It also presents examples of calculating incidence rates using data from cancer registries in India and describes the top 10 cancer sites reported in Bhopal.
This document defines and provides examples of key measures used to describe disease frequency in populations, including ratios, proportions, rates, odds, prevalence, and incidence. It discusses how prevalence represents the number of cases at a point in time, while incidence represents new cases over a period of time. Examples are provided to demonstrate calculating measures like cumulative incidence, incidence density, and attack rate. The relationship between incidence and prevalence over time is also explained.
This document discusses various methods for measuring disease frequency and occurrence in populations, including rates, ratios, proportions, prevalence, and incidence. It provides examples of how to calculate rates of prevalence and incidence. Prevalence is a measure of existing cases at a point in time, while incidence describes new cases occurring over time. Both are important for epidemiological research, disease surveillance, and health planning.
Introduction to epidemiology and it's measurementswrigveda
Epidemiology is defined as the study of the distribution and determinants of health-related states or events in specified populations. It has three main components - distribution, determinants, and frequency. Measurement of disease frequency involves quantifying disease occurrence and is a prerequisite for epidemiological investigation. Rates, ratios, and proportions are key tools used to measure disease frequency and distribution. Incidence rates measure new cases over time while prevalence rates measure existing cases. These measurements are essential for describing disease patterns, formulating hypotheses, and evaluating prevention programs.
1. The document discusses various epidemiological measurements including counts, rates, ratios, and proportions. It provides examples and formulas for calculating crude rates, adjusted rates, and specific rates.
2. Incidence is defined as the rate of new cases of a disease in a population over time. There are two approaches to measuring incidence - cumulative incidence rate and incidence density rate.
3. The document is a draft for a course on measurements and calculations in epidemiology, providing instruction on important concepts and formulas.
This document discusses various measurement tools used in epidemiology including rates, ratios, proportions, prevalence, and incidence. It provides examples of how to calculate crude rates, specific rates, ratios, and proportions. Prevalence refers to all existing cases at a point in time or over a period of time. Incidence refers only to new cases occurring over a time period. Relationships between incidence, prevalence, and duration of disease are also examined.
This document discusses various methods for measuring disease frequency and trends. It defines key epidemiological terms like prevalence, incidence, odds ratio, and relative risk. It explains how to calculate these measures and interpret them. For example, it shows how to calculate the odds ratio from a 2x2 table to measure the association between alcohol use and accidents. It also discusses factors that can indicate a causal relationship and gives examples of time series analysis of disease trends over time.
This document discusses different measures of morbidity including frequency, duration, and severity. Frequency is measured by incidence and prevalence. Incidence refers to new cases in a defined time period, while prevalence refers to all current cases. Duration is measured by disability rate and severity by case fatality rate. The document provides definitions and formulas for calculating incidence rate, point prevalence, and period prevalence. It also discusses factors that influence prevalence and the relationship between incidence and prevalence.
Crude Rate, Age Adjusted Rate, Age Specific Rates in CancerRamnath Takiar
This document provides an overview of basic statistical principles related to cancer registration. It defines key terms like cancer, cancer registration, crude rate, age-specific rate, and age-adjusted rate. It also presents examples of calculating incidence rates using data from cancer registries in India and describes the top 10 cancer sites reported in Bhopal.
This document defines and provides examples of key measures used to describe disease frequency in populations, including ratios, proportions, rates, odds, prevalence, and incidence. It discusses how prevalence represents the number of cases at a point in time, while incidence represents new cases over a period of time. Examples are provided to demonstrate calculating measures like cumulative incidence, incidence density, and attack rate. The relationship between incidence and prevalence over time is also explained.
This document discusses various methods for measuring disease frequency and occurrence in populations, including rates, ratios, proportions, prevalence, and incidence. It provides examples of how to calculate rates of prevalence and incidence. Prevalence is a measure of existing cases at a point in time, while incidence describes new cases occurring over time. Both are important for epidemiological research, disease surveillance, and health planning.
Introduction to epidemiology and it's measurementswrigveda
Epidemiology is defined as the study of the distribution and determinants of health-related states or events in specified populations. It has three main components - distribution, determinants, and frequency. Measurement of disease frequency involves quantifying disease occurrence and is a prerequisite for epidemiological investigation. Rates, ratios, and proportions are key tools used to measure disease frequency and distribution. Incidence rates measure new cases over time while prevalence rates measure existing cases. These measurements are essential for describing disease patterns, formulating hypotheses, and evaluating prevention programs.
This document provides information about health statistics in Malaysia. It notes that in 2009, the population of Malaysia was 27.9 million with 499,410 total births and 133,920 total deaths. This suggests the population in 2010 should be 28,265,490, though immigration and emigration may cause discrepancies. It also defines key health statistics terms like rates, ratios, proportions, and discusses calculating and adjusting rates.
There are several key measurements used in epidemiology:
1) Measurements include mortality, morbidity, disability, natality, disease attributes, healthcare services, and risk factors.
2) The main tools of measurement are proportions, rates, and ratios. Proportions do not include a time factor while rates and ratios do.
3) Measures of mortality include crude death rate, specific death rate, proportional mortality rate, case fatality rate, and standardized rates which allow for comparisons between populations. Morbidity is measured using incidence, which refers to new cases, and prevalence, which includes both new and old cases.
This document outlines key concepts and measures for quantifying disease occurrence in epidemiology. It discusses how disease is measured over time at the population level, and can be affected by age, period, and cohort effects. The key measures described are prevalence, incidence density (rate), and cumulative incidence (risk). Prevalence represents the proportion of a population with a disease at a given time, while incidence density and cumulative incidence incorporate the concept of person-time to account for differences in follow-up time.
This document defines and compares various epidemiological terms used to measure disease frequency and distribution in populations. It discusses rates, ratios, proportions, and their uses in measuring incidence, prevalence, mortality, and other disease determinants. Formulas are provided for calculating crude death rate, case fatality rate, and other measures. Factors that can impact prevalence over time are also explored.
This document discusses a systematic review and meta-analysis on the relationship between dietary fat intake and breast cancer risk. The meta-analysis included 45 studies with over 25,000 breast cancer patients. It found a small increased risk of breast cancer associated with higher total fat intake. The review also discusses terms related to systematic reviews and meta-analysis such as heterogeneity statistics, I2, and the Q statistic.
Rates and proportions are used to measure disease occurrence in epidemiology. Rates indicate how frequently a disease is occurring over time, while proportions show what portion of the population is affected. Risk refers to the probability of an individual developing a disease, while rates can estimate risk if time periods are short and incidence is constant. Incidence, prevalence, and attack rates are measures used, requiring information on events, population, and time period. Incidence density accounts for individuals' varying time at risk.
The prevalence rate as of June 30, 2012 is the number of active TB cases on that date (264) divided by the population on March 30, 2012 (183,000) and multiplied by 100,000.
264/183,000 = 144 per 100,000
The answer is c.
This document outlines a presentation on clinical epidemiology. It begins with an introduction to clinical epidemiology, noting that it was introduced in 1938 as a "new basic science for preventive medicine" and shifted its focus to individual patients in the 1960s. The document then defines clinical epidemiology as "the science of making predictions about individual patients by counting clinical events in similar patients." It discusses why clinical epidemiology is important for clinical decision making and avoiding bias. The rest of the document outlines topics to be covered, including uses of clinical epidemiology, sensitivity and specificity, predictive values, ROC curve analysis, and likelihood ratios.
Epidemiology lecture 2 measuring disease frequencyINAAMUL HAQ
This document discusses measuring disease frequency in epidemiology. It defines key terms like incidence, prevalence, population at risk, and rates. Incidence refers to new cases in a specified time period, while prevalence looks at total current cases. Prevalence can be point prevalence (at a point in time), period prevalence (over a specified time period), or lifetime prevalence. The document provides examples of calculating prevalence from population data and discusses how prevalence is used to understand disease burden and plan health services.
Incidence and prevalence measures provide information about disease frequency and burden in populations. Prevalence describes the proportion of people with a disease at a point in time, while incidence refers to the number of new cases that develop over time. Both measures can be stratified by person, place, and time to gain insights into a disease's pathogenesis and development.
This document discusses measures of disease occurrence, specifically prevalence and incidence rate. Prevalence is defined as the number of animals with the disease of interest at one point in time divided by the total population at risk. Incidence rate measures the average speed at which the disease is spreading by dividing the total new cases during a time period by the average number of animals at risk multiplied by the time period. While related, prevalence and incidence rate can differ based on the duration of the disease - a short but highly incident disease will have low prevalence, while a long but less incident disease can have high prevalence.
This document discusses various tools used to measure health indicators, including rates, ratios, and proportions. It provides definitions and examples of different types of rates that are used as mortality and morbidity indicators, such as crude death rate, specific death rates, infant mortality rate, and prevalence. These rates are calculated using a numerator (e.g. number of deaths) and denominator (e.g. population size), and provide information about the health status and needs of a population. Measuring these indicators helps health planners to assess health care needs, allocate resources, and evaluate programs.
This document summarizes key concepts in epidemiological studies. It discusses how epidemiological studies aim to determine the differences between those who get a disease and those who are spared. This is done by investigating the nature and extent of the disease, causative agents, sources of infection, modes of transmission and susceptibility of the population. The document also outlines the two main approaches in epidemiological investigations - asking questions and making comparisons. It provides examples of the types of questions asked and comparisons that can be made, such as between rural and urban populations. Finally, it defines epidemiological terms like case counts, rates, ratios and proportions that are used to measure and compare health outcomes.
The document discusses epidemiology and its applications. It defines epidemiology and describes its purposes such as preventing and controlling health problems. It outlines epidemiological methods like observational and experimental studies. Descriptive epidemiology aims to study disease frequency and distribution while analytical epidemiology tests hypotheses. The roles of nurses in applying epidemiological concepts to assess community health needs and evaluate prevention programs are also highlighted.
This document provides an introduction to basic epidemiology concepts. It defines epidemiology as the study of disease patterns in populations and the factors influencing these patterns. The document outlines key epidemiology concepts like prevalence, incidence, risk factors, exposures and outcomes. It discusses the history of epidemiology and different epidemiological study designs. Important epidemiology measures are also introduced, including various ways to define and calculate disease occurrence and frequency in populations.
This document discusses key concepts in statistical epidemiology including measures of disease frequency such as incidence rate and prevalence. It defines incidence rate as the number of new cases of a disease in a population over a time period, divided by the total population. Prevalence is defined as the total number of cases (new and existing) at a point in time, divided by the total population. Relative risk compares the risk of an event between exposed and unexposed groups, while attributable risk is the difference in risk between the two groups. Attributable fraction represents the proportion of disease cases among the exposed group that can be attributed to the exposure.
This document discusses various study designs used in medical research, including observational and experimental designs. It describes descriptive, analytical, and interventional studies. It provides examples of case reports, case series, cross-sectional studies, case-control studies, and cohort studies. It discusses key aspects of case-control studies such as selection of cases and controls, matching, determining exposure, and analyzing results. It also covers limitations and advantages of different study designs.
Epidemiology has several common practical applications. It is used to investigate infectious diseases through routine surveillance by health departments. Epidemiologists in hospitals explore causes of hospital-acquired infections. It also evaluates the impact of public health policies on trends like smoking rates and obesity. Overall, epidemiology provides data to understand community health issues and disease risks, identify disease syndromes, uncover disease causes, and evaluate treatments and interventions.
Morbidity has been defined as any departure, subjective or objective, from a state of physiological or psychological well-being. In practice, morbidity encompasses disease, injury, and disability.
This document provides an overview of epidemiology and public health. It discusses the definition of epidemiology as the study of the distribution and determinants of health-related states or events in populations. Epidemiology is used to describe disease occurrence, identify risk factors, and evaluate interventions. Key concepts covered include levels of prevention, health determinants, indicators, risk factors, and measures of population health. The document also summarizes different epidemiological study designs including observational and experimental studies and their ability to prove causation. Potential sources of error in epidemiological studies are also discussed.
This document discusses various indices used to summarize information, including ratios, proportions, and rates. It provides examples and definitions of each. Ratios are expressed as one number divided by another (a/b). Proportions are a ratio where the numerator is a subset of the denominator (a/(a+b)). Rates express the frequency of an event per unit of time and take the form of a ratio where the numerator is the number of events and the denominator is the total person-time at risk. The document also discusses how to calculate and interpret incidence rates, prevalence rates, and standardized mortality ratios.
Inferential statistics are used to draw conclusions about populations based on samples. The two primary inferential methods are estimation and hypothesis testing. Estimation involves using sample statistics to estimate unknown population parameters, such as means or proportions. Interval estimation provides a range of plausible values for the population parameter based on the sample data and a level of confidence, such as a 95% confidence interval. The width of the confidence interval depends on factors like the sample size, standard deviation, and desired confidence level.
This document provides information about health statistics in Malaysia. It notes that in 2009, the population of Malaysia was 27.9 million with 499,410 total births and 133,920 total deaths. This suggests the population in 2010 should be 28,265,490, though immigration and emigration may cause discrepancies. It also defines key health statistics terms like rates, ratios, proportions, and discusses calculating and adjusting rates.
There are several key measurements used in epidemiology:
1) Measurements include mortality, morbidity, disability, natality, disease attributes, healthcare services, and risk factors.
2) The main tools of measurement are proportions, rates, and ratios. Proportions do not include a time factor while rates and ratios do.
3) Measures of mortality include crude death rate, specific death rate, proportional mortality rate, case fatality rate, and standardized rates which allow for comparisons between populations. Morbidity is measured using incidence, which refers to new cases, and prevalence, which includes both new and old cases.
This document outlines key concepts and measures for quantifying disease occurrence in epidemiology. It discusses how disease is measured over time at the population level, and can be affected by age, period, and cohort effects. The key measures described are prevalence, incidence density (rate), and cumulative incidence (risk). Prevalence represents the proportion of a population with a disease at a given time, while incidence density and cumulative incidence incorporate the concept of person-time to account for differences in follow-up time.
This document defines and compares various epidemiological terms used to measure disease frequency and distribution in populations. It discusses rates, ratios, proportions, and their uses in measuring incidence, prevalence, mortality, and other disease determinants. Formulas are provided for calculating crude death rate, case fatality rate, and other measures. Factors that can impact prevalence over time are also explored.
This document discusses a systematic review and meta-analysis on the relationship between dietary fat intake and breast cancer risk. The meta-analysis included 45 studies with over 25,000 breast cancer patients. It found a small increased risk of breast cancer associated with higher total fat intake. The review also discusses terms related to systematic reviews and meta-analysis such as heterogeneity statistics, I2, and the Q statistic.
Rates and proportions are used to measure disease occurrence in epidemiology. Rates indicate how frequently a disease is occurring over time, while proportions show what portion of the population is affected. Risk refers to the probability of an individual developing a disease, while rates can estimate risk if time periods are short and incidence is constant. Incidence, prevalence, and attack rates are measures used, requiring information on events, population, and time period. Incidence density accounts for individuals' varying time at risk.
The prevalence rate as of June 30, 2012 is the number of active TB cases on that date (264) divided by the population on March 30, 2012 (183,000) and multiplied by 100,000.
264/183,000 = 144 per 100,000
The answer is c.
This document outlines a presentation on clinical epidemiology. It begins with an introduction to clinical epidemiology, noting that it was introduced in 1938 as a "new basic science for preventive medicine" and shifted its focus to individual patients in the 1960s. The document then defines clinical epidemiology as "the science of making predictions about individual patients by counting clinical events in similar patients." It discusses why clinical epidemiology is important for clinical decision making and avoiding bias. The rest of the document outlines topics to be covered, including uses of clinical epidemiology, sensitivity and specificity, predictive values, ROC curve analysis, and likelihood ratios.
Epidemiology lecture 2 measuring disease frequencyINAAMUL HAQ
This document discusses measuring disease frequency in epidemiology. It defines key terms like incidence, prevalence, population at risk, and rates. Incidence refers to new cases in a specified time period, while prevalence looks at total current cases. Prevalence can be point prevalence (at a point in time), period prevalence (over a specified time period), or lifetime prevalence. The document provides examples of calculating prevalence from population data and discusses how prevalence is used to understand disease burden and plan health services.
Incidence and prevalence measures provide information about disease frequency and burden in populations. Prevalence describes the proportion of people with a disease at a point in time, while incidence refers to the number of new cases that develop over time. Both measures can be stratified by person, place, and time to gain insights into a disease's pathogenesis and development.
This document discusses measures of disease occurrence, specifically prevalence and incidence rate. Prevalence is defined as the number of animals with the disease of interest at one point in time divided by the total population at risk. Incidence rate measures the average speed at which the disease is spreading by dividing the total new cases during a time period by the average number of animals at risk multiplied by the time period. While related, prevalence and incidence rate can differ based on the duration of the disease - a short but highly incident disease will have low prevalence, while a long but less incident disease can have high prevalence.
This document discusses various tools used to measure health indicators, including rates, ratios, and proportions. It provides definitions and examples of different types of rates that are used as mortality and morbidity indicators, such as crude death rate, specific death rates, infant mortality rate, and prevalence. These rates are calculated using a numerator (e.g. number of deaths) and denominator (e.g. population size), and provide information about the health status and needs of a population. Measuring these indicators helps health planners to assess health care needs, allocate resources, and evaluate programs.
This document summarizes key concepts in epidemiological studies. It discusses how epidemiological studies aim to determine the differences between those who get a disease and those who are spared. This is done by investigating the nature and extent of the disease, causative agents, sources of infection, modes of transmission and susceptibility of the population. The document also outlines the two main approaches in epidemiological investigations - asking questions and making comparisons. It provides examples of the types of questions asked and comparisons that can be made, such as between rural and urban populations. Finally, it defines epidemiological terms like case counts, rates, ratios and proportions that are used to measure and compare health outcomes.
The document discusses epidemiology and its applications. It defines epidemiology and describes its purposes such as preventing and controlling health problems. It outlines epidemiological methods like observational and experimental studies. Descriptive epidemiology aims to study disease frequency and distribution while analytical epidemiology tests hypotheses. The roles of nurses in applying epidemiological concepts to assess community health needs and evaluate prevention programs are also highlighted.
This document provides an introduction to basic epidemiology concepts. It defines epidemiology as the study of disease patterns in populations and the factors influencing these patterns. The document outlines key epidemiology concepts like prevalence, incidence, risk factors, exposures and outcomes. It discusses the history of epidemiology and different epidemiological study designs. Important epidemiology measures are also introduced, including various ways to define and calculate disease occurrence and frequency in populations.
This document discusses key concepts in statistical epidemiology including measures of disease frequency such as incidence rate and prevalence. It defines incidence rate as the number of new cases of a disease in a population over a time period, divided by the total population. Prevalence is defined as the total number of cases (new and existing) at a point in time, divided by the total population. Relative risk compares the risk of an event between exposed and unexposed groups, while attributable risk is the difference in risk between the two groups. Attributable fraction represents the proportion of disease cases among the exposed group that can be attributed to the exposure.
This document discusses various study designs used in medical research, including observational and experimental designs. It describes descriptive, analytical, and interventional studies. It provides examples of case reports, case series, cross-sectional studies, case-control studies, and cohort studies. It discusses key aspects of case-control studies such as selection of cases and controls, matching, determining exposure, and analyzing results. It also covers limitations and advantages of different study designs.
Epidemiology has several common practical applications. It is used to investigate infectious diseases through routine surveillance by health departments. Epidemiologists in hospitals explore causes of hospital-acquired infections. It also evaluates the impact of public health policies on trends like smoking rates and obesity. Overall, epidemiology provides data to understand community health issues and disease risks, identify disease syndromes, uncover disease causes, and evaluate treatments and interventions.
Morbidity has been defined as any departure, subjective or objective, from a state of physiological or psychological well-being. In practice, morbidity encompasses disease, injury, and disability.
This document provides an overview of epidemiology and public health. It discusses the definition of epidemiology as the study of the distribution and determinants of health-related states or events in populations. Epidemiology is used to describe disease occurrence, identify risk factors, and evaluate interventions. Key concepts covered include levels of prevention, health determinants, indicators, risk factors, and measures of population health. The document also summarizes different epidemiological study designs including observational and experimental studies and their ability to prove causation. Potential sources of error in epidemiological studies are also discussed.
This document discusses various indices used to summarize information, including ratios, proportions, and rates. It provides examples and definitions of each. Ratios are expressed as one number divided by another (a/b). Proportions are a ratio where the numerator is a subset of the denominator (a/(a+b)). Rates express the frequency of an event per unit of time and take the form of a ratio where the numerator is the number of events and the denominator is the total person-time at risk. The document also discusses how to calculate and interpret incidence rates, prevalence rates, and standardized mortality ratios.
Inferential statistics are used to draw conclusions about populations based on samples. The two primary inferential methods are estimation and hypothesis testing. Estimation involves using sample statistics to estimate unknown population parameters, such as means or proportions. Interval estimation provides a range of plausible values for the population parameter based on the sample data and a level of confidence, such as a 95% confidence interval. The width of the confidence interval depends on factors like the sample size, standard deviation, and desired confidence level.
Interval observer for uncertain time-varying SIR-SI model of vector-borne dis...FGV Brazil
The issue of state estimation is considered for an SIR-SI model describing a vector-borne disease such as dengue fever, with seasonal variations and uncertainties in the transmission rates. Assuming continuous measurement of the number of new infectives in the host population per unit time, a class of interval observers with estimate-dependent gain is constructed, and asymptotic error bounds are provided. The synthesis method is based on the search for a common linear Lyapunov function for monotone systems representing the evolution of the estimation errors.
Date: 2017
Authors:
Soledad Aronna, Maria
Bliman, Pierre-Alexandre
The document discusses mathematical models for analyzing the spread of infectious diseases and their application to problems related to bioterrorism defense and disease control. It describes models representing disease spread through social networks and thresholds for infection. Different vaccination strategies are analyzed and compared using these models on simple graphs. Discrete mathematics tools like threshold processes, independent sets, and conversion sets are introduced for modeling disease spread and determining optimal vaccination strategies.
Presentazione per il sesto WebMeetup del Machine Learning / Data Science Meetup Roma: https://www.meetup.com/it-IT/Machine-Learning-Data-Science-Meetup/events/273089965/
This document provides instructions and 10 questions for an examination in Probability and Mathematical Statistics. The questions cover a range of topics, including calculating summary statistics from sample data, probabilities related to sampling distributions, properties of distributions like Poisson and chi-square, hypothesis testing using t-tests and analysis of variance, confidence intervals, regression, and maximum likelihood estimation. Candidates are instructed to show their work and provide numerical answers for each part of each question. They have 3 hours to complete the exam.
This document defines and provides examples of different types of frequency measures used in epidemiology and public health, including ratios, proportions, rates, and other measures. It discusses how ratios, proportions, and rates are calculated, and provides specific formulas and examples. It also covers measures of morbidity like incidence and prevalence, and measures of mortality like crude mortality rates, cause-specific mortality rates, and others.
This document defines and provides examples of different types of frequency measures used in epidemiology and public health, including ratios, proportions, rates, and other measures. It discusses how ratios, proportions, and rates are calculated, and provides specific formulas and examples. It also covers measures of morbidity like incidence and prevalence, and measures of mortality like crude mortality rates, cause-specific mortality rates, and others.
The document provides an overview of populations, samples, and key concepts in descriptive statistics. It discusses how samples are used to make inferences about populations. Key points include:
- Samples are subsets of populations used for study due to constraints on time and resources.
- Descriptive statistics like means, medians, and histograms are calculated from samples to learn about characteristics of interest in populations.
- Categorical data can be summarized using frequency distributions and sample proportions.
- Different measures of center like the mean, median, and trimmed mean are used to summarize data, with the choice dependent on factors like outliers and distribution shape.
Measures of disease frequency include rates, ratios, and proportions. A ratio expresses the relation between two quantities where the numerator is not part of the denominator. A proportion indicates the relation of a part to the whole, with the numerator included in the denominator. A rate measures the occurrence of an event in a population during a time period. Other concepts discussed include incidence, prevalence, measures of central tendency (mean, median, mode), and measures of variation (range, standard deviation). Factors that can affect study outcomes include various types of biases such as selection, response, information, and confounding variables.
This document provides information about the t-test and chi-square test. It defines the t-test as a test used to compare the means of two samples when the population standard deviation is unknown. It lists the assumptions of the t-test and provides the formula. An example t-test problem and solution is given. Chi-square is introduced as a test used with categorical and numerical data to test for independence and goodness of fit. The chi-square test statistic, degrees of freedom, and hypothesis testing process are outlined. An example chi-square goodness of fit problem and solution is also provided.
Chi‑square Test and its Application in Hypothesis Testing
Rakesh Rana, Richa Singhal
Statistical Section, Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, GOI, New Delhi, India
This document discusses mathematical modeling of infectious diseases. It provides an overview of using mathematical models like logistic growth models to understand the dynamics of disease spread over time. Parameters from generalized Richards models and a novel growth rate equation are fitted to benchmark data from the 2003 SARS outbreak. The models are also fitted to COVID-19 data from Italy and Germany to analyze daily new cases and cumulative case numbers over time.
This project will investigate the SIR model and use numeric methods t.pdfjkcs20004
This project will investigate the SIR model and use numeric methods to find solutions to the
system of coupled, non-linear differential equations. We will work through the derivation of the
model and some assumptions. You will need to use technology, in the form of a spreadsheet
(Excel/Google Sheets) or computer code (C, C++, Python, Java, etc) to obtain approximate
numeric solutions. Some Background The SIR model is a very useful compartmental model to
help understand the spread of disease through a population during some given time. The
mathematical model has three compartments: Susceptible members of the population (S),
Infected members of the population (I), and Recovered-or Removed-members of the population
(R). As with any mathematical model we will make some assumptions that we should be mindful
of when using this in a "real-world" context. Lets begin with some initial information. 1. We will
assume, for simplicity, that the number of susceptible individuals in a population at some time t
can be given by the function S(t), and further that each of the infected and removed individuals
will be given by functions I(t) and R(t) respectively. 2. We can also assume that for a population
N,S(t)+I(t)+R(t)=N. Explain why this is a reasonable assumption. 3. We will also assume that the
population we are studying is closed, that is we never add to the susceptible members and that
once removed, you will not be susceptible. Explain why this simplification may not reflect a
real-world scenario. Deriving some differential equations: First, lets look at how the susceptible
population might be changing. We will fix a model parameter, called , that will be the number of
daily contacts each infected person has with a susceptible person resulting in disease infection.
We can write it like this: dtdS=NS(t)I(t) Explain why this is reasonable. Why is there an I(t) ?
Why do we have NS(t) ? Why is it negative?
For reasons of convenience, instead of considering the change in numbers of each compartment
we will look at the change in proportion of each compartment, so we can say that:
s(t)=NS(t)i(t)=NI(t)r(t)=NR(t) We will get the following changes: s(t)+i(t)+r(t)=1 and the
differential equation for change in proportion of susceptible will be: dtds=s(t)i(t) Now consider
the change in removed proportion. For this we will need to introduce another parameter, , which
you can think of as a fixed proportion of the infected members who will be recovered/removed
each day or as the recovery rate: 1/ (days to recover). So we get: dtdr=i(t) We know that
s(t)+i(t)+r(t)=1, so it follows that if we take the derivative with respect to t we get:
dtd(s(t)+i(t)+r(t))=dtd(1) Write the resulting equation below: Use the equation you found to
solve for dtdi and substitute to find dtdi in terms of the model parameters and , and the functions
s(t),i(t),r(t). Write it below:
Together these three equations give a system of coupled, non-linear differential equations. Fill in
the missing e.
1) The document discusses different measures used to quantify disease occurrence and epidemiological data, including counts, rates, proportions, and ratios. It explains concepts like incidence, prevalence, cumulative incidence, and incidence rate.
2) Examples are provided for calculating ratios, proportions, incidence risk, and incidence rate using hypothetical population and disease data. The examples illustrate how to determine the population at risk and calculate the measures.
3) An attack rate is defined as the number of new cases in a population during an outbreak divided by the initial population at risk. It is expressed as a percentage to quantify the proportion of a population that develops disease during an outbreak.
MEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACTAneesa K Ayoob
This document discusses various measures used to quantify disease frequency, association, and impact in epidemiology. It defines key terms like incidence, prevalence, risk, rate, and ratio. For measures of disease frequency, it distinguishes between incidence, which considers new cases over time, and prevalence, which includes all current cases. Measures of association like relative risk and odds ratio quantify the relationship between exposure and outcome by comparing disease occurrence between exposed and unexposed groups. Measures of impact, such as attributable risk, indicate the extent to which a disease can be attributed to a given exposure.
This document provides an outline and introduction to statistical tools and SPSS used in social research. It covers topics such as data presentation, measures of central tendency, skewness and kurtosis, measures of dispersion, correlation, and regression. The document defines key statistical concepts and terms and provides examples of how to calculate statistics like the mean, median, mode, and percentiles for both ungrouped and grouped data sets. Formulas and calculation methods are presented.
Mathematical Model for Infection and Removalijtsrd
The document presents a mathematical model for studying the spread of infectious diseases within a community. It envisions a population of n individuals comprising x susceptible individuals, y infectious individuals, and z recovered/immune individuals at time t. Infection and removal rates (β and γ) are postulated. The model is represented as damped harmonic oscillations where the body's resistance to infection decays over time similar to damped motion. Solving the model equations results in a solution indicating seasonal variation in infections. Modifications to the model are discussed, including allowing for an incubation period between infection and becoming infectious. The model can provide insight into disease spread and evaluate control strategies.
The document discusses hypothesis testing and statistical analysis techniques. It covers univariate, bivariate, and multivariate statistical analysis, which involve one, two, or three or more variables, respectively. The key steps of hypothesis testing are outlined, including deriving a null hypothesis from the research objectives, obtaining and measuring a sample, comparing the sample value to the hypothesis, and determining whether to support or not support the hypothesis based on consistency. Type I and Type II errors in hypothesis testing are defined. Common statistical tests like chi-square, t-tests, ANOVA, and correlation are introduced along with concepts like significance levels, p-values, and degrees of freedom.
Top of Form1. Stream quality is based on the levels of many .docxedwardmarivel
Top of Form
1.
Stream quality is based on the levels of many variables, including the following. Which of these variables is quantitative?
The amount of dissolved oxygen
The number of distinct species present
The amount of phosphorus
All of the above
2.
Which of the following is a discrete variable?
Weight of a fish
Length of a fish
None of the above
Number of toxins present in a fish
3.
During winter, red foxes hunt small rodents by jumping into thick snow cover. Researchers report that a hunting trip lasts on average 19 minutes and involves on average 7 jumps. They also report that, surprisingly, 79% of all successful jumps are made in the northeast direction. Three variables are mentioned in this report. The first variable mentioned is
ordinal.
quantitative and discrete.
quantitative and continuous.
categorical.
4.
A sample of 55 streams in severe distress was obtained during 2007. The following is a bar graph of the number of streams that are from the Northeast, Northwest, Southeast, or Southwest. In the bar graph, the bar for the Northeast has been omitted.
The number of streams from the Northeast is
35.
25.
15.
45.
5.
Here is a stemplot (with split stems) of body temperatures (in degrees Fahrenheit) for 65 healthy adult women.
The first quartile for this data set is
97.6.
97.5.
98.0.
97.9.
6.
Researchers measured the length of the central retrix (R1), a flight-involved tail feather, in 21 female long-tailed finches. Here is a boxplot of the length, in millimeters (mm).
Based on this boxplot, which of the following statements is TRUE?
The distribution of R1 lengths is bimodal.
The distribution of R1 lengths is mildly right-skewed with a high outlier.
75% of the birds in this study had an R1 length above 70 mm.
All of the above
7.
Geckos are lizards with specialized toe pads that enable them to easily climb all sorts of surfaces. A research team examined the adhesive properties of 7 Tokay geckos. Below are their toe-pad areas (in square centimeters, cm2).
5.6
4.9
6.0
5.1
5.5
5.1
7.5
To be an outlier, an observation must fall outside the range
4.9 to 7.5.
4.2 to 6.9.
3.75 to 7.35.
5.1 to 6.0.
8.
The median age of five people on a committee is 30 years. One of the members, whose age is 50 years, resigns. The median age of the remaining four people in the committee is
not able to be determined from the information given.
25 years.
30 years.
40 years.
9.
By inspection, determine which of the following sets of numbers has the smallest standard deviation.
7, 8, 9, 10
0, 0, 10, 10
0, 1, 2, 3
5, 5, 5, 5
10.
The volume of oxygen consumed (in liters per minute) while a person is at rest and while he or she is exercising (running on a treadmill) was measured for each of 50 subjects. The goal is to determine if the volume of oxygen consumed during aerobic exercise can be estimated from the amount consumed at rest. The results are plotted below.
The scatterplot sugges ...
Dr Swati Rajagopal_ ADULT VACCINATION.pptxVandanaVats8
This document discusses adult immunization guidelines in India. It covers several common vaccines recommended for adults such as the influenza, tetanus/diphtheria/pertussis, pneumococcal, hepatitis A and B, herpes zoster, and HPV vaccines. For each vaccine, it describes the types available, indications for use, dosage, schedule, precautions, and high-risk groups. The document emphasizes that while childhood immunization is widespread in India, awareness and uptake of adult vaccines remains low despite the significant disease burden they can prevent.
This document discusses adult immunization and vaccination. It covers the basics of immunity and the immune system. It describes the different types of vaccines including live, inactivated, conjugate, and combination vaccines. It discusses the various routes of administration including oral, intranasal, subcutaneous, intramuscular, and intradermal. Recommendations are provided for various adult vaccines including Tdap, MMR, varicella, HPV, hepatitis A and B, pneumococcal, influenza, and meningococcal vaccines. A table outlines the recommended vaccines for different adult age groups.
Bacterial vaccines have helped eliminate or reduce several infectious diseases. Common bacterial vaccines protect against diphtheria, tetanus, pertussis, pneumococcal disease, Hib, meningococcal meningitis, typhoid, cholera and more. Vaccines work through active immunization by vaccination or passive immunization using antibodies. Ongoing research continues to develop new vaccines and improve vaccine effectiveness.
1. Implement a patient intake form to routinely assess vaccination status at every visit and identify which vaccines are needed.
2. Use standing orders and protocols to allow nurses and other staff to administer recommended vaccines.
3. Refer patients to pharmacies or health departments for vaccines not stocked in the practice and document referrals.
3. Enter administered vaccines and referrals into the state immunization registry to track rates and prevent missed opportunities.
The document provides guidance on vaccinations for adults ages 19 years and older. It includes:
1) A table outlining recommended vaccinations by age group, including COVID-19, influenza, tetanus/diphtheria/pertussis, measles/mumps/rubella, varicella, zoster, human papillomavirus, pneumococcal, hepatitis A&B, meningococcal, and Haemophilus influenzae type b vaccines.
2) A table listing additional vaccination recommendations for those with medical conditions or other indications, such as pregnancy, immunocompromised individuals, and health care workers.
3) Notes providing details on COVID-19 vaccination
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
2. Modelling of Pandemics
• Pandemics such as plague, flu, cholera exhibit sharp rise and fall:
Spanish flu deaths in UK (Source: https://doi.org/10.3201/eid1201.050979, CC)
3. Modelling of Pandemics
• To explain this phenomenon, Kermack-McKendrik (1927) proposed a
mathematical model called SIR model.
• Susceptible: population not yet infected
• Infected: population with infection
• Removed: population no longer infected (includes fatalities)
Susceptible Infected Removed
4. SIR Model
• Let 𝑆(𝑡), 𝐼(𝑡), and 𝑅(𝑡) represent fraction of population in each of
three groups at time 𝑡.
• Susceptible get infected in proportion to both 𝑆(𝑡) and 𝐼(𝑡):
• Suppose an infected person meets k persons per day and transfers infection
to each with probability p.
• Then one infected person newly infects 𝑝𝑘𝑆 = 𝛽𝑆 persons in one day.
• Therefore, fraction of infected persons in one day is:
𝑆(𝑡) + 𝐼(𝑡) + 𝑅(𝑡) = 1
𝑑𝑆
𝑑𝑡
= −𝛽𝑆𝐼
5. SIR Model
• Infected get removed in proportion to 𝐼(𝑡):
• 𝐼(𝑡) changes with new infections coming in and earlier infected
removed:
𝑑𝐼
𝑑𝑡
= 𝛽𝑆𝐼 − 𝛾𝐼
𝑑𝑅
𝑑𝑡
= 𝛾𝐼
6. SIR Model
• Fatalities 𝐷(𝑡) are a subset of 𝑅(𝑡) and change in 𝐷(𝑡) is also
proportional to 𝐼(𝑡):
• Constants 𝛽, 𝛾, and 𝜂 determine the trajectory of the pandemic.
𝑑𝐷
𝑑𝑡
= 𝜂𝐼
Traditionally estimated by studying virus properties,
population dynamics, and healthcare infrastructure.
7. A Property of SIR Model
• Let 𝑁(𝑡) denote fraction of new infections at time t.
• Then:
• Alternately:
𝑁 = 𝛽𝑆𝐼 = 𝛽 1 − 𝐼 − 𝑅 𝐼 = 𝛽𝐼 − 𝛽 𝐼 + 𝑅 𝐼
𝐼 =
1
𝛽
𝑁 + 𝐼 + 𝑅 𝐼
8. A Property of SIR Model
• Let 𝑁 𝑡 = 𝑃0𝑁 𝑡 , 𝐼 𝑡 = 𝑃0𝐼 𝑡 , 𝑅 𝑡 = 𝑃0𝑅 𝑡 denote respective
actual numbers at time t.
• Then:
𝐼 =
1
𝛽
𝑁 +
1
𝑃0
𝐼 + 𝑅 𝐼
9. A Property of SIR Model
• This demonstrates a linear relationship between 𝐼, 𝑁, and 𝐼 + 𝑅 𝐼.
• If above three quantities can be measured, then parameter 𝛽 can be
estimated.
The problem is that reported values of infections may differ greatly
from actual values.
That is why epidemiologists need to use other methods to estimate
parameter values.
10. SEIR Model
• In some diseases, e.g. measles, an infected person starts infecting
after a gestation period. This was captured by a variant called SEIR
model.
• Exposed: infected population that is not yet spreading to others
• Infected: infected population that is spreading to others
Susceptible Exposed Infected Removed
11. SEIR Model
• Let 𝑆(𝑡), 𝐸(𝑡), 𝐼(𝑡), and 𝑅(𝑡) represent fraction of population in each
of four groups at time 𝑡.
• Dynamics:
𝑆 𝑡 + 𝐸 𝑡 + 𝐼(𝑡) + 𝑅(𝑡) = 1
𝑑𝑆
𝑑𝑡
= −𝛽𝑆𝐼
𝑑𝐸
𝑑𝑡
= 𝛽𝑆𝐼 − 𝛼𝐸
𝑑𝐼
𝑑𝑡
= 𝛼𝐸 − 𝛾𝐼
𝑑𝑅
𝑑𝑡
= 𝛾𝐼
Adding 𝐸 and 𝐼 reduces to SIR model.
12. SAIR Model
• In some diseases, e.g. Covid-19, an infected person can remain
asymptomatic but still infect others.
• This is captured by a variant called SAIR model.
• Asymptomatic: infected asymptomatic population
• Infected: infected population with symptoms
• Removed: splits into two – Removed Asymptomatic and Removed Infected
Susceptible Asymptomatic
Removed
Infected Removed
13. SAIR Model
• Let 𝑆(𝑡), 𝐴(𝑡), 𝐼(𝑡), 𝑅𝐴(𝑡) and 𝑅𝐼(𝑡) represent fraction of population
in each of five groups at time 𝑡.
• Dynamics:
𝑆 𝑡 + 𝐴 𝑡 + 𝐼 𝑡 + 𝑅𝐴 𝑡 + 𝑅𝐼(𝑡) = 1
𝑑𝑆
𝑑𝑡
= −𝛽𝑆(𝐴 + 𝐼)
𝑑𝐴
𝑑𝑡
= 𝛽𝑆 𝐴 + 𝐼 − 𝛿𝐴 − 𝛾𝐴
𝑑𝐼
𝑑𝑡
= 𝛿𝐴 − 𝛾𝐼
𝑑𝑅𝐴
𝑑𝑡
= 𝛾𝐴
𝑑𝑅𝐼
𝑑𝑡
= 𝛾𝐼
Adding 𝐴 and 𝐼, 𝑅𝐴 and 𝑅𝐼 reduces to SIR model
14. COVID-19 Pandemic
• Different than earlier pandemics:
• Most of these asymptomatic cases are not detected, and continue
passing infection to others.
• Nearly all cases with severe symptoms get detected.
Has a large number of asymptomatic cases
Without detecting, how does one estimate asymptomatic cases?
15. Modelling Spread of Pandemic
• Due to this, estimating becomes more difficult since even
denominator is not known.
• No model has studied this so far.
The spread of pandemic has been controlled in most countries
How does one estimate spread of the pandemic at different time?
16. Modelling Spread of Pandemic
• Let 𝑃(𝑡) denote the population of region within reach of the
pandemic at time 𝑡.
• Define 𝜌 = 𝑃/𝑃0, a new parameter that increases over time from 0 to
1, where 𝑃0 is the total population of the region.
• Parameter 𝜌 is called reach of the pandemic.
17. COVID-19 Pandemic
• On the positive side, extensive data is available for the first time
about pandemic progression in different regions.
• Under-reporting and testing limitations take reported data even
further away from actual numbers.
Can one use reported data to estimate parameter values?
18. A Question
• Let
• 𝑁𝑇 𝑡 denote fraction of daily reported infections,
• 𝑇(𝑡) fraction of reported active infections, and
• 𝑅𝑇(𝑡) fraction of cumulative removed among reported infections at time t.
• Data available is 𝑇 𝑡 = 𝜌𝑃0𝑇, 𝑅𝑇(𝑡) = 𝜌𝑃0𝑅𝑇, and 𝑁𝑇 𝑡 = 𝜌𝑃0𝑁𝑇
as daily time series.
Is there any relationship between these three measurable quantities?
19. A Hypothesis
𝑇, 𝑁𝑇 and 𝑇 + 𝑅𝑇 𝑇 satisfy linear relation:
𝑇 = 𝑏𝑁𝑇 +
𝑒
𝑃0
𝑇 + 𝑅𝑇 𝑇
To verify, we plot 𝑇 − 𝑏𝑁𝑇 against 𝑇 + 𝑅𝑇 𝑇 for suitably chosen 𝑏
Recall that we have: 𝐼 =
1
𝛽
𝑁 +
1
𝑃0
𝐼 + 𝑅 𝐼
21. India Data
b = 6.38
e = 917
R2 = 0.999
-20000.0
0.0
20000.0
40000.0
60000.0
80000.0
100000.0
120000.0
140000.0
160000.0
0.0 50000000000.0 100000000000.0 150000000000.0 200000000000.0 250000000000.0
T
–
b*
N
T * (T + RT)
April 29 – June 20, 2020
22. India Data
b = 6.29
e = 165
R2 = 0.999
0.0
200000.0
400000.0
600000.0
800000.0
1000000.0
1200000.0
1400000.0
0.0 2000000000000.0 4000000000000.0 6000000000000.0 8000000000000.0 10000000000000.0 12000000000000.0
T
–
b
*
N
T * (T + RT)
July 21 – August 21, 2020
23. India Data
b = 6.68
e = 82
R2 = 0.999
0.0
500000.0
1000000.0
1500000.0
2000000.0
2500000.0
0.0 5000000000000.0 10000000000000.0 15000000000000.0 20000000000000.0 25000000000000.0 30000000000000.0 35000000000000.0 40000000000000.0
T
–
b
*
N
T * (T + RT)
September 21 – November 1, 2020
24. India Data
b = 4.93
e = 83.6
R2 = 0.999
0.0
500000.0
1000000.0
1500000.0
2000000.0
2500000.0
0.0 5000000000000.0 10000000000000.0 15000000000000.0 20000000000000.0 25000000000000.0 30000000000000.0 35000000000000.0
T
–
b
*
N
T * (T + RT)
November 12 – December 31, 2020
25. India Data
b = 4.29
e = 83.1
R2 = 0.999
0.0
100000.0
200000.0
300000.0
400000.0
500000.0
600000.0
700000.0
800000.0
900000.0
11000000000000.0 11500000000000.0 12000000000000.0 12500000000000.0 13000000000000.0 13500000000000.0
T
–
b
*
N
T * (T + RT)
January 22 – January 31, 2021
26. India Data
b = 2.64
e = 68.3
R2 = 0.999
0.0
200000.0
400000.0
600000.0
800000.0
1000000.0
1200000.0
1400000.0
0.0 5000000000000.0 10000000000000.0 15000000000000.0 20000000000000.0 25000000000000.0 30000000000000.0
T
–
b
*
N
T * (T + RT)
March 22 – March 28, 2021
27. India Data
b = 3.52
e = 38.6
R2 = 0.999
0.0
2000000.0
4000000.0
6000000.0
8000000.0
10000000.0
12000000.0
14000000.0
16000000.0
18000000.0
0.0 100000000000000.0 200000000000000.0 300000000000000.0 400000000000000.0 500000000000000.0 600000000000000.0 700000000000000.0
T
–
b
*
N
T * (T + RT)
April 24 – May 17, 2021
28. Observations
• There are nine different phases with different values of b and e
• Is this unique to India?
The equation holds for ~62% days in the entire timeline
Simulations of 26 countries, 35 states and UTs, and 200+ districts
of India show same phenomenon!
29. US Data
b = 3.14
e = 483.0
R2 = 0.999
US data is taken from https://datahub.io/core/covid-19#resource-time-series-19-covid-combined
-100000.0
0.0
100000.0
200000.0
300000.0
400000.0
500000.0
600000.0
700000.0
800000.0
0.0 100000000000.0 200000000000.0 300000000000.0 400000000000.0 500000000000.0 600000000000.0 700000000000.0
T
–
b
*
N
T * (T + RT)
March 18 – April 12, 2020
30. US Data
b = 6.75
e = 78.8
R2 = 0.985
0.0
100000.0
200000.0
300000.0
400000.0
500000.0
600000.0
700000.0
800000.0
2300000000000.0 2400000000000.0 2500000000000.0 2600000000000.0 2700000000000.0 2800000000000.0 2900000000000.0
T
–
b
*
N
T * (T + RT)
May 15 – June 10, 2020
31. US Data
b = 5.80
e = 29.8
R2 = 0.998
0.0
500000.0
1000000.0
1500000.0
2000000.0
2500000.0
0.0 5000000000000.0 10000000000000.0 15000000000000.0 20000000000000.0 25000000000000.0
T
–
b
*
N
T * (T + RT)
June 21 – September 09, 2020
32. US Data
b = 4.27
e = 14.2
R2 = 0.990
0.0
500000.0
1000000.0
1500000.0
2000000.0
2500000.0
3000000.0
3500000.0
4000000.0
4500000.0
0.0 20000000000000.0 40000000000000.0 60000000000000.0 80000000000000.0 100000000000000.0
T
–
b
*
N
T * (T + RT)
October 28 – November 30, 2020
33. US Data
b = 4.34
e = 10.6
R2 = 0.999
0.0
1000000.0
2000000.0
3000000.0
4000000.0
5000000.0
6000000.0
7000000.0
8000000.0
9000000.0
0.0 50000000000000.0 100000000000000.0 150000000000000.0 200000000000000.0 250000000000000.0 300000000000000.0
T
–
b
*
N
T * (T + RT)
December 11 – December 29, 2020
34. US Data
b = 3.67
e = 9.2
R2 = 0.999
0.0
2000000.0
4000000.0
6000000.0
8000000.0
10000000.0
12000000.0
0.0 50000000000000.0 100000000000000.0 150000000000000.0 200000000000000.0 250000000000000.0 300000000000000.0 350000000000000.0 400000000000000.0
T
–
b
*
N
T * (T + RT)
January 4 – February 18, 2021
35. US Data
b = 4.39
e = 7.7
R2 = 0.998
0.0
500000.0
1000000.0
1500000.0
2000000.0
2500000.0
3000000.0
3500000.0
4000000.0
4500000.0
5000000.0
150000000000000.0 155000000000000.0 160000000000000.0 165000000000000.0 170000000000000.0 175000000000000.0 180000000000000.0 185000000000000.0
T
–
b
*
N
T * (T + RT)
February 26 – March 7, 2021
36. US Data
b = 1.98
e = 8.6
R2 = 0.999
0.0
500000.0
1000000.0
1500000.0
2000000.0
2500000.0
3000000.0
3500000.0
4000000.0
4500000.0
0.0 20000000000000.0 40000000000000.0 60000000000000.0 80000000000000.0 100000000000000.0 120000000000000.0 140000000000000.0 160000000000000.0
T
–
b
*
N
T * (T + RT)
March 24 – May 22, 2021
37. Observations
• There are eight different phases with different values of b and e
• For both India and US, value of e starts high and reduces rapidly
The equation holds for ~70% days in the entire timeline
e Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 Phase 6 Phase 7 Phase 8 Phase 9
India 5759253.2 39164.2 917.1 165.0 81.9 83.6 83.1 68.3 43.3
US 483.0 78.8 29.8 14.2 10.6 9.2 7.7 8.6 -
38. Questions
Why does equation hold for majority of days?
Why does equation not hold for some days?
What is meaning of rapidly decreasing value of 𝑒?
40. SUTRA Model
• Group 𝑈: infected but undetected population
• It will mostly consist of asymptomatic cases
• Group 𝑇: infected and tested positive population
• Most of symptomatic cases will be in 𝑇
Susceptible Undetected
Removed
Tested +ve Removed
A at the end stands for Approach
41. SUTRA Model
• Let 𝑆(𝑡), 𝑈(𝑡), 𝑇(𝑡), 𝑅𝑈(𝑡) and 𝑅𝑇(𝑡) represent fraction of
population in each of five groups at time 𝑡.
• Dynamics:
𝑆 𝑡 + 𝑈 𝑡 + 𝑇 𝑡 + 𝑅𝑈 𝑡 + 𝑅𝑇(𝑡) = 1
𝑑𝑆
𝑑𝑡
= −𝛽𝑆𝑈
𝑑𝑈
𝑑𝑡
= 𝛽𝑆𝑈 − 𝑁𝑇 − 𝛾𝑈
𝑑𝑇
𝑑𝑡
= 𝑁𝑇 − 𝛾𝑇
𝑑𝑅𝑈
𝑑𝑡
= 𝛾𝑈
𝑑𝑅𝑇
𝑑𝑡
= 𝛾𝑇
Adding 𝑈 and 𝑇, 𝑅𝑈 and 𝑅𝑇 reduces to SIR model
42. SUTRA Model: Transition from U to T
• As in SAIR model, we can choose 𝑁𝑇 = 𝛿𝑈
• However, this is not a good choice since only recently infected move
from 𝑈 to 𝑇
• Due to contact tracing protocol
• Also, analysis is hard
• Idea: 𝑘𝛽𝑆𝑈 is a better approximation of size of recently infected
population for constant 𝑘.
• Hence, set 𝑁𝑇 = 𝛿𝑘𝛽𝑆𝑈 = 𝜖𝛽𝑆𝑈
• This also makes the analysis very neat!
46. SUTRA Model: Analysis
• Resulting in:
• With 𝑏 =
1
𝛽 1−𝜖 1−𝑐
and 𝑒 =
1
𝜖𝜌(1−𝑐)
.
𝑇 =
1
𝛽 1 − 𝜖 1 − 𝑐
𝑁𝑇 +
1
𝜖𝜌 1 − 𝑐 𝑃0
𝑇 + 𝑅𝑇 𝑇
= 𝑏𝑁𝑇 +
𝑒
𝑃0
𝑇 + 𝑅𝑇 𝑇 Fundamental sutra of the model
47. SUTRA Model: Parameters
• 𝛽 : Contact rate, governs speed at which people get infected
• 𝛾 : Removal rate, governs speed at which infected people get removed
• 𝜂 : Mortality rate
• 𝜖 : Ratio of detected to total infections
• 𝑐 : Constant connecting 𝑅𝑇 to 𝑅𝑈.
• 𝜌 : reach of the pandemic
48. Estimation of Parameters
• Also available is 𝐷 𝑡 = 𝜌𝑃0𝐷 as daily time series
• Using equations
values of 𝛾 and 𝜂 can be calculated.
𝑑𝑅𝑇
𝑑𝑡
= 𝛾𝑇,
𝑑𝐷
𝑑𝑡
= 𝜂𝑇
Standard least square error method is used in estimation
49. Estimation of Parameters
• From the fundamental sutra:
values of 𝑏 =
1
𝛽(1−𝜖)(1−𝑐)
and 𝑒 =
1
𝜖𝜌(1−𝑐)
can be calculated.
• These values change over time, as observed in example data.
• Change of these values is called a phase change.
𝑇 = 𝑏𝑁𝑇 +
𝑒
𝑃0
(𝑇 + 𝑅𝑇)𝑇
50. Causes of Phase Change
• Lockdowns, personal protection measures reduce 𝛽
• Crowding and mutants increase 𝛽
• Testing policies change 𝜖
• Spread of infection to new areas increases 𝜌
It is reasonable to assume that parameter values drift for some
time after phase change and then stabilize.
51. Answers to Questions
SUTRA model shows why equation holds for majority of days
Equation does not hold for some days due to drift in parameter
values
Value of 𝑒 is large at beginning due to small value of 𝜌 and it
reduces as 𝜌 increases
52. Estimation of Parameters
• How does one estimate 𝛽 and 𝜌 from
1
𝑏
= 𝛽(1 − 𝜖)(1 − 𝑐) and
1
𝑒
=
𝜖𝜌(1 − 𝑐)?
• Define function 𝑓: 0,1 × [−1,1] as:
• On input (𝑟, 𝑠), set 𝜌 = 𝑟 and 𝑐 = 𝑠, compute 𝛽 and 𝜖, and use it to compute
trajectory of 𝑈 and 𝑅𝑈 for current phase. Compare with 𝑇 and 𝑅𝑇 to estimate
𝑇 + 𝑅𝑇 =
1
𝑎
𝑈 + 𝑅𝑈 + 𝑠′. Output (
𝑎+1
𝑒𝑎 1−𝑠′ , 𝑠′).
• Value (𝜌, 𝑐) is a fix-point of 𝑓.
Experimentally, it is found that 𝑓 has unique fix-point that can be
found quickly by iterating 𝑓 fifteen times from a random point.
53. India: Parameter Values
Start Date Drift Period β η 1/ϵ ρ (in %)
Phase 1 02-03-2020 5 0.33 ±0.03 0.002 ±0.0005 37 0 ±0
Phase 2 20-03-2020 0 0.26 ±0.01 0.0063 ±0.0004 37 ±0 0.1 ±0
Phase 3 24-04-2020 5 0.16 ±0 0.0041 ±0.0002 37 ±0 4 ±0.4
Phase 4 21-06-2020 30 0.16 ±0 0.0019 ±0.0001 37 ±0 22.4 ±1.5
Phase 5 22-08-2020 10 0.15 ±0 0.0012 ±0 37 ±0 45.2 ±1.2
Phase 6 02-11-2020 10 0.21 ±0.04 0.0011 ±0 37 ±0 44.3 ±5.9
Phase 7 01-01-2021 10 0.22 ±0.01 0.0009 ±0 37 ±0 44.5 ±1.1
Phase 8 10-02-2021 40 0.39 ±0.01 0.0008 ±0 37 ±0 54.2 ±1.3
Phase 9 29-03-2021 26 0.33 ±0.02 0.0011 ±0 37 ±0 85.3 ±4.9
We fix 𝛾 = 0.1
These values should be taken with a pinch of salt, as they
depend on calibration chosen. However, percentage change is
independent of calibration.
54. India: Pandemic Spread Simulation
0
50
100
150
200
250
300
350
400
450
3/1/2020 4/20/2020 6/9/2020 7/29/2020 9/17/2020 11/6/2020 12/26/2020 2/14/2021 4/5/2021 5/25/2021
Infections
Thousands
Date
Detected New Infections (7 day average)
Actual Data Model Computed on 29th April
55. US: Parameter Values
Start Date Drift Period β η 1/ϵ ρ (in %)
Phase 1 15-03-2020 3 0.4 ±0.02 0.0091 ±0.0002 5 1 ±0.1
Phase 2 13-04-2020 32 0.19 ±0 0.0049 ±0.0003 5 ±0 6.3 ±0.2
Phase 3 11-06-2020 10 0.21 ±0.01 0.0017 ±0 5.1 ±0.1 17.1 ±1.2
Phase 4 13-09-2020 45 0.29 ±0.01 0.0012 ±0 5.1 ±0 36.1 ±1.3
Phase 5 01-12-2020 10 0.29 ±0.02 0.0013 ±0 5.2 ±0 48.8 ±3.1
Phase 6 30-12-2020 5 0.34 ±0.02 0.0016 ±0 5.2 ±0 56.5 ±1.5
Phase 7 19-02-2021 7 0.28 ±0.03 0.0023 ±0.0001 5.2 ±0 67.3 ±3.2
Phase 8 08-03-2021 16 0.61 ±0.1 0.0013 ±0.0001 5.6 ±0.4 65.3 ±6.7
We fix 𝛾 = 0.1
These values should be taken with a pinch of salt, as they
depend on calibration chosen. However, percentage change is
independent of calibration.
56. US: Pandemic Spread Simulation
0
50
100
150
200
250
300
3/10/2020 6/8/2020 9/6/2020 12/5/2020 3/5/2021 6/3/2021
Infections
Thousands
Date
Detected New Infections (7 day average)
Actual Data Model Computed Data
57. UP: Pandemic Spread Simulation
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
5/1/2020 7/30/2020 10/28/2020 1/26/2021 4/26/2021
Infections
Date
Detected New Infections
Actual Data Model Computed on 9th May
58. Kanpur: Pandemic Spread Simulation
0
500
1000
1500
2000
2500
5/1/2020 7/30/2020 10/28/2020 1/26/2021 4/26/2021
Infections
Date
Detected New Infections (7 day average)
Actual Data Model Computed on 6th May
More simulations at www.sutra-india.in
59. Strengths and Weaknesses of the Model
• Strengths:
• Probably the first model that can estimate values of all parameters only from
daily reported infections and deaths data
• Can provide an excellent understanding of the past
• Can provide future projections up to medium term, assuming that parameters
do not change significantly
• Can provide what-if analysis through setting parameters to different values
• Weaknesses:
• During drift period, estimating parameter values is difficult and so predictions
are likely to be wrong
• Cannot predict future values of parameters
60. Future Work
• Incorporate loss of immunity over time
• Needs regular serosurvey data for validation
• Incorporate immunity induced by vaccination
• Prove that, under reasonable conditions, function f has a unique fixed
point
• Find a way of estimating stable parameter values during initial drift
period of a phase